Trial intelligence / Profile preview

Dexamethasone vs Prednisolone in Childhood ALL and LNHL

NCT00003728Phase 3Unknown

Sponsor
European Organisation for Research and Treatment of Cancer
Start
Dec 1998
Primary completion
May 2008
Modality
Orthosteric Ligands, Replacement Enzymes
Countries
3
01

Overview

A Phase 3 trial of dexamethasone, prednisolone, asparaginase escherichia coli in acute lymphoblastic leukemia (ALL), lymphoblastic lymphoma (LBL), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.

02

Drugs

dexamethasoneprednisoloneasparaginase escherichia coli
03

Conditions

acute lymphoblastic leukemia (ALL)lymphoblastic lymphoma (LBL)

Beyond the preview

Go deeper on NCT00003728.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00003728.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call